Latest Washington University School of Medicine Stories
Personalized medicine centers on being able to predict the risk of disease or response to a drug based on a person's genetic makeup.
Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson's disease get into a patient's brain and affect blood flow in several key structures, an indicator the drug may be effective.
Health care providers can play a key role in the fight against weight problems in young people.
Students who enter medical school with high debt levels, low scores on the Medical College Admissions Test (MCAT) or who are non-white are more likely to face difficulties that may prevent graduation or hinder acceptance into a residency program if they do graduate.
NEW YORK, May 17 /PRNewswire-FirstCall/ -- In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. (NYSE: PFE) will give scientists at Washington University School of Medicine in St.
Girls and young women who drink alcohol increase their risk of benign (noncancerous) breast disease, says a study by researchers at Washington University School of Medicine in St. Louis and Harvard University.
Children with asthma who continue to have symptoms while using low-dose inhaled corticosteroids could benefit from increasing the dosage or adding one of two asthma drugs, a new study by researchers at Washington University School of Medicine and other institutions finds.
A type of antibiotic that can cause hearing loss in people has been found to paradoxically protect the ears when given in extended low doses in very young mice.
Older patients with acute myeloid leukemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off.
Individuals who begin drinking at an early age are more likely to subsequently develop alcohol dependence (AD). While age at first drink (AFD) and AD are influenced by similar genetic and environmental factors, AFD may also have an impact on the risk for AD. A new study has found that AFD may facilitate the expression of genes that are already associated with vulnerability to AD symptoms.